A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis
Surosree Ganguli,1 Peter DeLeeuw,2 Sanjaya K Satapathy3 1Division of Internal Medicine, University of Louisville, Louisville, KY 40202, USA; 2Division of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA; 3Division of Hepatology and Sandra Atlas Bass Center for...
Enregistré dans:
Auteurs principaux: | Ganguli S, DeLeeuw P, Satapathy SK |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/acfb6ebad0b44dd59bdcc63f07870f85 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
par: Justine Gillard, et autres
Publié: (2022) -
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates
par: Philippe Garteiser, et autres
Publié: (2021) -
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease
par: Bradford V, et autres
Publié: (2013) -
PI3Kγ promotes obesity-associated hepatocellular carcinoma by regulating metabolism and inflammation
par: Barbara Becattini, et autres
Publié: (2021) -
Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt
par: Osama Hamdy, et autres
Publié: (2021)